KALA BIO
KALA
106 hedge funds and large institutions have $249M invested in KALA BIO in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 19 closing their positions.
0% more capital invested
Capital invested by funds: $248M → $249M (+$335K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0.03% → 0.02% (-0%)
5% less funds holding
Funds holding: 112 → 106 (-6)
10% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 29
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
28% less call options, than puts
Call options by funds: $2.97M | Put options by funds: $4.12M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.32M |
| 2 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$2.26M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.27M |
| 4 |
BlackRock
New York
|
+$1.23M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$625K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$2.99M |
| 2 |
Two Sigma Investments
New York
|
-$2.3M |
| 3 |
Millennium Management
New York
|
-$976K |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$976K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$917K |
KALA Hedge Fund Activity: Q1 2021 in Review
106 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2021, worth a combined $249M — up 0.13% from $248M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of KALA and 14 opened new positions — a net loss of 5 holders — while 29 trimmed existing stakes and 26 added.
The largest buyer was Deutsche Bank, adding an estimated $2.32M. The largest seller was Bank of America, cutting an estimated $2.99M.
- 106 institutional investors held KALA BIO (KALA) as of Q1 2021, down from 112 in Q4 2020.
- Funds reported $249M of KALA BIO stock for Q1 2021, up 0.13% quarter-over-quarter.
- 14 funds opened new KALA BIO positions in Q1 2021 and 19 closed out, a net change of -5 holders.
- The largest KALA BIO buyer in Q1 2021 was Deutsche Bank, an estimated $2.32M added.
- The largest KALA BIO seller in Q1 2021 was Bank of America, an estimated $2.99M sold.
Based on aggregated 13F filings for Q1 2021.